Earnings Feed
Start Free
|4Feb 3, 3:39 PM ET

AEOLUS PHARMACEUTICALS, INC. 4

4 · AEOLUS PHARMACEUTICALS, INC. · Filed Feb 3, 2016

Insider Transaction Report

Form 4
Period: 2013-10-01
AEOLUS PHARMACEUTICALS, INC.AOLS
Clerici John
Director
Transactions
  • Award

    Non-qualified Stock Option (right to buy)

    2014-10-01+75,000→ 75,000 total
    Exercise: $0.24Exp: 2024-10-01→ Common Stock (75,000 underlying)
  • Award

    Non-qualified Stock Option (right to buy)

    2013-10-01+75,000→ 75,000 total
    Exercise: $0.26Exp: 2023-10-01→ Common Stock (75,000 underlying)
  • Award

    Non-qualified Stock Option (right to buy)

    2015-10-01+75,000→ 75,000 total
    Exercise: $0.25Exp: 2025-10-01→ Common Stock (75,000 underlying)
Footnotes (1)
  • [F1]Option will vest in equal monthly installments over a period of twelve months from the date of grant, provided that the Director remains on the Board of Directors of the Company.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT